These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38372405)

  • 1. Prevalence of CYP2D6 structural variation in large retrospective study.
    Frear S; Sherman A; Rule D; Marcath LA
    Pharmacogenet Genomics; 2024 Jun; 34(4):135-138. PubMed ID: 38372405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of CYP2D6 Haplotypes that Interfere with Commonly Used Assays for Copy Number Variation Characterization.
    Turner AJ; Aggarwal P; Boone EC; Haidar CE; Relling MV; Derezinski AD; Broeckel U; Gaedigk A
    J Mol Diagn; 2021 May; 23(5):577-588. PubMed ID: 33631352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of undetected CYP2D6 hybrid genes in clinical samples: impact on phenotype prediction.
    Black JL; Walker DL; O'Kane DJ; Harmandayan M
    Drug Metab Dispos; 2012 Jan; 40(1):111-9. PubMed ID: 22004686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants.
    Gaedigk A; Jaime LK; Bertino JS; Bérard A; Pratt VM; Bradfordand LD; Leeder JS
    Front Pharmacol; 2010; 1():121. PubMed ID: 21833166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction.
    Gaedigk A; Fuhr U; Johnson C; Bérard LA; Bradford D; Leeder JS
    Pharmacogenomics; 2010 Jan; 11(1):43-53. PubMed ID: 20017671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR.
    Gaedigk A; Twist GP; Leeder JS
    Pharmacogenomics; 2012 Jan; 13(1):91-111. PubMed ID: 22111604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6 (*) 15 and (*) 35 Genotyping.
    Riffel AK; Dehghani M; Hartshorne T; Floyd KC; Leeder JS; Rosenblatt KP; Gaedigk A
    Front Pharmacol; 2015; 6():312. PubMed ID: 26793106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of complex structural variation in the
    Turner AJ; Derezinski AD; Gaedigk A; Berres ME; Gregornik DB; Brown K; Broeckel U; Scharer G
    Front Pharmacol; 2023; 14():1195778. PubMed ID: 37426826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential quantification of CYP2D6 gene copy number by four different quantitative real-time PCR assays.
    Ramamoorthy A; Flockhart DA; Hosono N; Kubo M; Nakamura Y; Skaar TC
    Pharmacogenet Genomics; 2010 Jul; 20(7):451-4. PubMed ID: 20421845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model.
    Lee SB; Wheeler MM; Patterson K; McGee S; Dalton R; Woodahl EL; Gaedigk A; Thummel KE; Nickerson DA
    Genet Med; 2019 Feb; 21(2):361-372. PubMed ID: 29875422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unequal cross-over event within the CYP2D gene cluster generates a chimeric CYP2D7/CYP2D6 gene which is associated with the poor metabolizer phenotype.
    Panserat S; Mura C; Gérard N; Vincent-Viry M; Galteau MM; Jacoz-Aigrain E; Krishnamoorthy R
    Br J Clin Pharmacol; 1995 Oct; 40(4):361-7. PubMed ID: 8554938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype.
    Daly AK; Fairbrother KS; Andreassen OA; London SJ; Idle JR; Steen VM
    Pharmacogenetics; 1996 Aug; 6(4):319-28. PubMed ID: 8873218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication.
    Langaee T; Hamadeh I; Chapman AB; Gums JG; Johnson JA
    PLoS One; 2015; 10(1):e0113808. PubMed ID: 25625348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D7 splice variants in human liver and brain: does CYP2D7 encode functional protein?
    Gaedigk A; Gaedigk R; Leeder JS
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1241-50. PubMed ID: 16169517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cas9 targeted nanopore sequencing with enhanced variant calling improves CYP2D6-CYP2D7 hybrid allele genotyping.
    Rubben K; Tilleman L; Deserranno K; Tytgat O; Deforce D; Van Nieuwerburgh F
    PLoS Genet; 2022 Sep; 18(9):e1010176. PubMed ID: 36149915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of the Important Role of
    Taylor C; Crosby I; Yip V; Maguire P; Pirmohamed M; Turner RM
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33143137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexities of CYP2D6 gene analysis and interpretation.
    Gaedigk A
    Int Rev Psychiatry; 2013 Oct; 25(5):534-53. PubMed ID: 24151800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cypiripi: exact genotyping of CYP2D6 using high-throughput sequencing data.
    Numanagić I; Malikić S; Pratt VM; Skaar TC; Flockhart DA; Sahinalp SC
    Bioinformatics; 2015 Jun; 31(12):i27-34. PubMed ID: 26072492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing.
    Buermans HP; Vossen RH; Anvar SY; Allard WG; Guchelaar HJ; White SJ; den Dunnen JT; Swen JJ; van der Straaten T
    Hum Mutat; 2017 Mar; 38(3):310-316. PubMed ID: 28044414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR.
    Schaeffeler E; Schwab M; Eichelbaum M; Zanger UM
    Hum Mutat; 2003 Dec; 22(6):476-85. PubMed ID: 14635107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.